| Date Filed | Type | Description |
| 11/12/2021 |
4
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 4 on Doximity, Inc.|
Txns:
| Converted 17,070,350 shares
@ $0
Disposed of 8,535,175 shares
@ $0
Converted 17,070,350 options to buy
@ $0 |
|
| 06/28/2021 |
4
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 4 on Doximity, Inc.|
Txns:
| Converted 15,410,874 preferred shares
@ $0
Converted 1,659,476 preferred shares
@ $0
Converted 17,070,350 options to buy
@ $0 |
|
| 06/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/10/2020 |
SC 13G/A
| MORGENTHALER VENTURE PARTNERS IX LP reports a 0% stake in Principia Biopharma Inc. |
| 03/08/2019 |
SC 13D/A
| MORGENTHALER VENTURE PARTNERS IX LP reports a 4.7% stake in Ra Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G
| MORGENTHALER VENTURE PARTNERS IX LP reports a 5.7% stake in Vapotherm, Inc. |
| 02/13/2019 |
SC 13G
| MORGENTHALER VENTURE PARTNERS IX LP reports a 9.3% stake in Principia Biopharma Inc. |
| 01/22/2019 |
SC 13D/A
| MORGENTHALER VENTURE PARTNERS IX LP reports a 6.1% stake in Ra Pharmaceuticals, Inc. |
| 01/07/2019 |
SC 13D/A
| MORGENTHALER VENTURE PARTNERS IX LP reports a 7.1% stake in Ra Pharmaceuticals, Inc. |
| 11/20/2018 |
4
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 4 on VAPOTHERM INC|
Txns:
| Converted 921,348 shares
@ $0
Converted 61,342 shares
@ $0
Converted 214,285 convertible preferred
@ $0
Converted 217,803 convertible preferred
@ $0
Converted 359,842 convertible preferred
@ $0
Converted 129,418 convertible preferred
@ $0
Converted 61,342 convertible preferred
@ $0 |
|
| 11/13/2018 |
3
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 3 on VAPOTHERM INC |
| 09/13/2018 |
3
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 3 on Principia Biopharma Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 06/01/2017 |
4
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 4 on Calithera Biosciences, Inc. |
| 11/04/2016 |
SC 13D
| MORGENTHALER VENTURE PARTNERS IX LP reports a 19% stake in Ra Pharmaceuticals, Inc. |
| 10/31/2016 |
4
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 4 on Ra Pharmaceuticals, Inc. |
| 10/25/2016 |
3
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 3 on Ra Pharmaceuticals, Inc. |
| 02/12/2016 |
SC 13G/A
| MORGENTHALER VENTURE PARTNERS IX LP reports a 1.4% stake in LendingClub Corporation |
| 02/12/2016 |
SC 13G/A
| MORGENTHALER VENTURE PARTNERS IX LP reports a 11.9% stake in Calithera Biosciences, Inc. |
| 02/17/2015 |
SC 13G
| MORGENTHALER VENTURE PARTNERS IX LP reports a 12.1% stake in Calithera Biosciences, Inc. |
| 02/17/2015 |
SC 13G
| MORGENTHALER VENTURE PARTNERS IX LP reports a 7.9% stake in LendingClub Corporation |
| 10/09/2014 |
4
| MORGENTHALER VENTURE PARTNERS IX LP (10% Owner) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Converted 1,811,915 shares
@ $10, valued at
$18.1M
Bought 350,000 shares
@ $10, valued at
$3.5M
Converted 10,999 preferred shares
@ $0
Converted 419,181 preferred shares
@ $0
Converted 747,540 preferred shares
@ $0
Converted 634,195 preferred shares
@ $0 |
|
| 02/05/2009 |
REGDEX/A
| Form REGDEX/A -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] [amend] |